Caris Life Sciences Inc. (CAI)
Caris Life Sciences Max Pain By Strike
CAI trades at $36.18, 3.4% above the near-term max pain of $35 expiring Sep 19, 2025 (30 days). Price stability likely with balanced options positioning at this level. Max pain is rising across expirations ($15-$35), reflecting growing call interest at higher strikes. High dispersion in max pain levels suggests competing forces and potential volatility.
Caris Life Sciences Max Pain By Expiry
Max pain for CAI shows an upward trend from 15 to 35, suggesting bullish positioning in longer-dated options. The 76% spread signals divergent expectations across timeframes. Most levels below 36.18 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 35 | -1.18 (-3.26%) |
| Oct 17, 2025 | 25 | -11.18 (-30.90%) |
| Jan 16, 2026 | 30 | -6.18 (-17.08%) |
| Apr 17, 2026 | 15 | -21.18 (-58.54%) |